Paris, France

Armelle Phalipon

USPTO Granted Patents = 7 


 

Average Co-Inventor Count = 5.9

ph-index = 2

Forward Citations = 16(Granted Patents)


Location History:

  • 75015 Paris, FR (2003)
  • Paris, FR (2012 - 2019)

Company Filing History:


Years Active: 2003-2019

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Armelle Phalipon: Innovator in Glycoconjugate Research

Introduction

Armelle Phalipon is a prominent inventor based in Paris, France. He has made significant contributions to the field of glycoconjugate research, particularly in the development of potential vaccines against infections. With a total of seven patents to his name, Phalipon is recognized for his innovative approaches to vaccine formulation.

Latest Patents

Phalipon's latest patents focus on glycoconjugates and their applications as potential vaccines. One of his notable inventions involves a conjugate comprising an oligo- or polysaccharide that is bound to a carrier. This invention aims to enhance the efficacy of vaccines against specific infections. Additionally, he has developed compounds derived from sugars that reproduce the epitopes of serotypes 3a and X. These compounds are intended for use in vaccine compositions and diagnostic methods for infections.

Career Highlights

Throughout his career, Armelle Phalipon has worked with esteemed institutions such as Institut Pasteur and the Institut National de la Santé et de la Recherche Médicale. His work at these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research in immunology and vaccine development.

Collaborations

Phalipon has collaborated with notable colleagues, including Philippe J. Sansonetti and Farida Nato. These partnerships have further enriched his research and have led to advancements in the understanding of glycoconjugates and their potential applications in medicine.

Conclusion

Armelle Phalipon is a distinguished inventor whose work in glycoconjugate research has the potential to revolutionize vaccine development. His innovative patents and collaborations with leading institutions highlight his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…